Literature DB >> 25091354

Comparison of intragastric balloon therapy and intensive lifestyle modification therapy with respect to weight reduction and abdominal fat distribution in super-obese Japanese patients.

Masahiro Takihata1, Akinobu Nakamura1, Kazutaka Aoki1, Mari Kimura1, Yusuke Sekino2, Masahiko Inamori3, Shin Maeda2, Eiji Gotoh4, Atsushi Nakajima2, Yasuo Terauchi5.   

Abstract

This study compared the impacts of intragastric balloon (IGB) therapy and intensive lifestyle modification therapy on abdominal fat distribution. Sixteen extremely obese Japanese patients were assigned to an intensive lifestyle modification therapy group with educational hospitalisation (8 patients) or an IGB therapy group (8 patients) and were followed up for 6 months. The main outcome measures were the differences at 6 months, relative to the baseline values, in the visceral fat area (VFA), subcutaneous fat area (SFA), and liver volume as measured using computed tomography. At 0 month, the body weights (BWs) were 121.3±19.0 kg and 127.1±24.4 kg and the VFAs were 299±55 cm2 and 257±56 cm2 in the intensive lifestyle modification therapy group and the IGB therapy group, respectively. No statistically significant differences in the baseline characteristics were observed between these two groups. At 6 months, no difference in the changes in BW from the baseline value (-11.5 [-16.4, -6.6] kg vs. -11.2 [-18.9, -3.4] kg) was seen between the two groups. However, a statistically significant difference in the change in the VFA (-66 [-87, -44] cm2 vs. -22 [-70, 26]cm(2) [P=0.027]) was observed; no significant changes in the SFA or liver volume were seen. In conclusion, IGB therapy was as effective as intensive lifestyle modification therapy for weight reduction but was less effective with respect to the improvement in abdominal visceral fat accumulation and liver steatosis in super-obese Japanese patients.
Copyright © 2013 Asian Oceanian Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Abdominal fat distribution; Intragastric balloon therapy; Super-obese patients

Mesh:

Substances:

Year:  2013        PMID: 25091354     DOI: 10.1016/j.orcp.2013.07.002

Source DB:  PubMed          Journal:  Obes Res Clin Pract        ISSN: 1871-403X            Impact factor:   2.288


  9 in total

Review 1.  Efficacy and Safety of Intragastric Balloon (IGB) in Non-alcoholic Fatty Liver Disease (NAFLD): a Comprehensive Review and Meta-analysis.

Authors:  Saurabh Chandan; Babu P Mohan; Shahab R Khan; Antonio Facciorusso; Daryl Ramai; Lena L Kassab; Neil Bhogal; Ravishankar Asokkumar; Gortrand Lopez-Nava; Stephanie McDonough; Douglas G Adler
Journal:  Obes Surg       Date:  2021-01-06       Impact factor: 4.129

Review 2.  The Impact of Intragastric Balloons on Obesity-Related Co-Morbidities: A Systematic Review and Meta-Analysis.

Authors:  Violeta B Popov; Amy Ou; Allison R Schulman; Christopher C Thompson
Journal:  Am J Gastroenterol       Date:  2017-01-24       Impact factor: 10.864

3.  Endoscopic Bariatric and Metabolic Therapies and Their Effects on Metabolic Syndrome and Non-alcoholic Fatty Liver Disease - A Systematic Review and Meta-Analysis.

Authors:  Shi-Yan Lee; Haoxing Lai; Yang Jie Chua; Min Xian Wang; Guan-Huei Lee
Journal:  Front Med (Lausanne)       Date:  2022-05-09

Review 4.  Effect of Intragastric Balloons on Liver Enzymes: A Systematic Review and Meta-Analysis.

Authors:  Violeta B Popov; Christopher C Thompson; Nitin Kumar; Maria M Ciarleglio; Yanhong Deng; Loren Laine
Journal:  Dig Dis Sci       Date:  2016-05-20       Impact factor: 3.199

5.  The Effect of a Lifestyle Modification Education on Adiposity Measures in Overweight and Obese Nonalcoholic Fatty Liver Disease Patients.

Authors:  Arman Arab; Gholamreza Askari; Parastoo Golshiri; Awat Feizi; Ali Hekmatnia; Bijan Iraj; Mojgan Nourian
Journal:  Int J Prev Med       Date:  2017-02-23

6.  Effects of Bariatric Endoscopy on Non-Alcoholic Fatty Liver Disease: A Comprehensive Systematic Review and Meta-Analysis.

Authors:  Mengting Ren; Xinxin Zhou; Yunyun Zhang; Feifei Mo; Jinpu Yang; Mosang Yu; Feng Ji
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-17       Impact factor: 6.055

7.  Efficacy of Intragastric Balloons in the Markers of Metabolic Dysfunction-associated Fatty Liver Disease: Results from Meta-analyses.

Authors:  Zi-Yuan Zou; Jing Zeng; Tian-Yi Ren; Yi-Wen Shi; Rui-Xu Yang; Jian-Gao Fan
Journal:  J Clin Transl Hepatol       Date:  2021-03-16

8.  Short-term effects of intragastric balloon in association with conservative therapy on weight loss: a meta-analysis.

Authors:  Yiyuan Zheng; Miao Wang; Songhua He; Guang Ji
Journal:  J Transl Med       Date:  2015-07-29       Impact factor: 5.531

9.  A Comparison of the Weight Loss Effect between a Low-carbohydrate Diet and a Calorie-restricted Diet in Combination with Intragastric Balloon Therapy.

Authors:  Satoshi Maekawa; Makoto Niizawa; Masaru Harada
Journal:  Intern Med       Date:  2020-05-01       Impact factor: 1.271

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.